Page 406 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 406
Cochrane Hepato-Biliary 120 C
Rigshospitalet, Dept. 7812,
Blegdamsvej 9
Copenhagen, DK-2100
Denmark
hbg.cochrane.org
The CHB, part ofThe Cochrane Collaboration, is a non-profit, international clinical research
group with about 2000 members. Cochrane systematic reviews of interventions for hepatic
and biliary diseases are our main product. In issue 1, 2014 of The Cochrane Library, we
published 276 peer-reviewed protocols for systematic reviews and 179 systematic reviews. A
CHBG Register with about 15000 references on randomised or controlled clinical trials is
maintained in the CENTRAL database in The Cochrane Library. Cochrane reviews are not
industry funded.You are welcome to work with us! Come to booth 120C!
EASL - The European Association for the Study of the Liver 510
The Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland
www.easl.eu
EASL is a medical society and the leading liver association in Europe. It aims to promote
liver research and improve the treatment of liver disease throughout the world.
In the 50 years since it was founded, EASL has grown from a small organisation to becoming
the home of Hepatology - a leading liver association with over 4000 hepatology experts as
members, and attracting over 10,000 participants at its annual congress.
INDUSTRY INFORMATION ELPA – European Liver Patients Association 200 B
F. De Renesselaan, 57
Sint Truiden, B 3800
Belgium
www.elpa-info.org
ELPA emerged from a desire amongst European liver patient groups to share their
experiences. In June 2004, 13 patient groups from 10 countries created the association.
ELPA was formally launched in Paris on April 14th 2005. It now has 34 members in 26
countries. ELPA's aim is to promote the interests of people with liver disease, to highlight
the size of the problem; promote awareness and prevention; address the low profile of liver
disease compared to other areas of medicine; share experience of successful initiatives;
and work with professional bodies such as EASL to ensure that treatment and care are
harmonised.
406 The International Liver Congress™ 2015 • ILC Programme
Rigshospitalet, Dept. 7812,
Blegdamsvej 9
Copenhagen, DK-2100
Denmark
hbg.cochrane.org
The CHB, part ofThe Cochrane Collaboration, is a non-profit, international clinical research
group with about 2000 members. Cochrane systematic reviews of interventions for hepatic
and biliary diseases are our main product. In issue 1, 2014 of The Cochrane Library, we
published 276 peer-reviewed protocols for systematic reviews and 179 systematic reviews. A
CHBG Register with about 15000 references on randomised or controlled clinical trials is
maintained in the CENTRAL database in The Cochrane Library. Cochrane reviews are not
industry funded.You are welcome to work with us! Come to booth 120C!
EASL - The European Association for the Study of the Liver 510
The Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland
www.easl.eu
EASL is a medical society and the leading liver association in Europe. It aims to promote
liver research and improve the treatment of liver disease throughout the world.
In the 50 years since it was founded, EASL has grown from a small organisation to becoming
the home of Hepatology - a leading liver association with over 4000 hepatology experts as
members, and attracting over 10,000 participants at its annual congress.
INDUSTRY INFORMATION ELPA – European Liver Patients Association 200 B
F. De Renesselaan, 57
Sint Truiden, B 3800
Belgium
www.elpa-info.org
ELPA emerged from a desire amongst European liver patient groups to share their
experiences. In June 2004, 13 patient groups from 10 countries created the association.
ELPA was formally launched in Paris on April 14th 2005. It now has 34 members in 26
countries. ELPA's aim is to promote the interests of people with liver disease, to highlight
the size of the problem; promote awareness and prevention; address the low profile of liver
disease compared to other areas of medicine; share experience of successful initiatives;
and work with professional bodies such as EASL to ensure that treatment and care are
harmonised.
406 The International Liver Congress™ 2015 • ILC Programme
